医学信息Issue(11)：343-343,1.
依达拉奉联合尤瑞克林治疗急性脑梗塞的临床疗效研究
Research on the Clinical Efficacy for the Treatment of Acute Cerebral Infarction with Edaravone and Urinary Kallidinogenase
陈铸雄 1杨凤珠2
作者信息
- 1. 肇庆市第一人民医院急诊科，广东 肇庆 526060
- 2. 肇庆市第一人民医院神经内科，广东 肇庆 526060
- 折叠
摘要
Abstract
Objective To investigate the application ef icacy and safety of the edaravone and Urinary Kal idinogenase in the clinical treatment of acute cerebral infarction. Methods Group A treatment for edaravone and Urinary Kal idinogenase,group B treatment for edaravone. Results The edaravone and Urinary Kal idinogenase treatment was significantly bet er than with edaravone (P<0.05), total ef ective treatment, group A compared edaravone group also statistical y significant (P<0.05). Conclusion Edaravone and Urinary Kal idinogenase, with low morbidity and good clinical ef icacy in the treatment of acute cerebral infarction, can ef ectively improve the patient's self-care ability.关键词
依达拉奉/尤瑞克林/急性脑梗塞Key words
Edaravone/the Urinary Kallidinogenase/Acute cerebral infarction引用本文复制引用
陈铸雄,杨凤珠..依达拉奉联合尤瑞克林治疗急性脑梗塞的临床疗效研究[J].医学信息,2013,(11):343-343,1.
